1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer
Gulis, K. LU
; Rydén, L.
LU
; Bendahl, P. O.
LU
and Svensjö, T.
LU
(2021)
In World Journal of Surgery
45(5).
p.1433-1441
- Contribution to journal › Article
-
Mark
Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data
Ellbrant, J. LU ; Gulis, K. LU
; Plasgård, E.
; Svensjö, T.
; Bendahl, P. O.
LU
and Rydén, L.
LU
(2021)
In BJS Open
5(5).
- Contribution to journal › Article
-
Mark
Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer
Majid, S. LU ; Bendahl, P. O. LU ; Huss, L. LU ; Manjer, J. LU ; Rydén, L. LU
and Dihge, L.
LU
(2021)
In BJS Open
5(3).
- Contribution to journal › Article
-
Mark
St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
Narbe, U. LU ; Bendahl, P. O. LU ; Fernö, M. LU ; Ingvar, C. LU ; Dihge, L. LU and Rydén, L. LU
(2021)
In The British journal of surgery
108(12).
p.1465-1473
- Contribution to journal › Article
- 2020
-
Mark
Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment : Study protocol for the ReScreen randomized controlled trial
- Contribution to journal › Article
-
Mark
Cosmetic outcome and symmetry for patients who have undergone bilateral therapeutic mammoplasty for breast cancer
Gulis, K. LU
; Bendahl, P. O.
LU
; Svensjö, T.
LU
and Rydén, L.
LU
(2020)
In European Journal of Cancer
138.
p.33-33
- Contribution to journal › Article
- 2019
-
Mark
A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews
- Contribution to journal › Scientific review
-
Mark
Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial
Ekholm, M. LU ; Bendahl, P. O. LU ; Fernö, M. LU ; Nordenskjöld, B. ; Stål, O. and Rydén, L. LU
(2019)
In European Journal of Cancer
110.
p.53-61
- Contribution to journal › Article
- 2017
-
Mark
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer : the Danish cohort of BIG 1-98
Alkner, S. LU ; Jensen, Brian M. ; Rasmussen, Birgitte B. ; Bendahl, P. O. LU ; Fernö, M. LU ; Rydén, L. LU
and Mouridsen, H.
(2017)
In Breast Cancer Research and Treatment
166.
p.481-490
- Contribution to journal › Article
- 2015
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
Aaltonen, K. E. LU ; Graffman, C. LU ; Larsson, A. M. LU and Rydén, L. LU
(2015)
In Annals of Oncology
26(Suppl. 3).
p.15-15
- Contribution to journal › Article